Valeant (VRX) Divests Paragon Holdings to Settle FTC Antitrust Charges
11/8/2016 7:17:53 AM
Valeant Pharmaceuticals, which owns eye care products maker Bausch & Lomb, has agreed to sell Paragon Holdings to settle allegations that its acquisition of the smaller company was illegal under antitrust law, the Federal Trade Commission said on Monday.
The FTC said that Bausch & Lomb and Paragon together made more than 70% of three kinds of polymer discs used to make gas-permeable contact lenses. The sale will undo Valeant’s May 2015 purchase of Paragon.
comments powered by